Screener
Maravai LifeSciences Holdings, Inc. MRVI Europe, the Middle East and Africa — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $51,442 | $47,397 | $117,279 | $94,247 |
| Cost of revenue | 30,792 | 39,629 | 62,928 | 78,754 |
| Gross profit | 20,650 | 7,768 | 54,351 | 15,493 |
| Operating expenses: | ||||
| Selling, general and administrative | 32,070 | 38,715 | 61,162 | 78,279 |
| Research and development | 3,702 | 4,882 | 7,591 | 9,770 |
| Goodwill impairment | — | 30,449 | — | 42,884 |
| Restructuring | (33) | — | 2,845 | — |
Item 1. Financial Statements
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported europe, the middle east and africa — revenue of $10.45M in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue increased by 24.5% year-over-year, from $8.4M to $10.45M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue has grown at a -47.2% compound annual growth rate (CAGR), from $397.67M to $30.92M.
- What does europe, the middle east and africa — revenue mean?
- This metric represents the total net sales generated from customers located within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and demand for nucleic acid production and biologics safety testing products within these specific international markets. Monitoring this figure helps investors assess the company's global footprint and the performance of its regional sales and distribution strategies.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude